These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 196753)
1. Combination chemotherapy with adriamycin and cyclophosphamide (with or without radiation therapy) for carcinoma of the lung. Herman TS; Jones SE; McMahon LJ; Lloyd RE; Heusinkveld RS; Miller RC; Salmon SE Cancer Treat Rep; 1977 Aug; 61(5):875-9. PubMed ID: 196753 [No Abstract] [Full Text] [Related]
2. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung]. Sanz Ortiz J; Saiz García F Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560 [No Abstract] [Full Text] [Related]
3. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report. Takita H; Marabella PC; Edgerton F; Rizzo D Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692 [No Abstract] [Full Text] [Related]
4. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma. Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920 [TBL] [Abstract][Full Text] [Related]
5. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725 [No Abstract] [Full Text] [Related]
6. Cyclophosphamide, adriamycin, and DTIC polychemotherapy in advanced small cell lung cancer. Saiontz HI; Dalton RJ; Eagan RT Cancer Treat Rep; 1977; 61(3):481-3. PubMed ID: 194692 [No Abstract] [Full Text] [Related]
7. The treatment of lung cancer. Zubrod CG; Selawry O Adv Intern Med; 1978; 23():451-67. PubMed ID: 204171 [No Abstract] [Full Text] [Related]
8. Four-drug combination chemotherapy in extensive non-small cell lung cancer: a Southwest Oncology Group Pilot Study. Livingston RB; Mira J; O'Bryan RM Cancer Treat Rep; 1981; 65(1-2):143-4. PubMed ID: 6164484 [No Abstract] [Full Text] [Related]
9. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer. Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763 [TBL] [Abstract][Full Text] [Related]
10. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study. Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987 [TBL] [Abstract][Full Text] [Related]
11. Combination cyclophosphamide, doxorubicin, and cisplatin (CAP) chemotherapy for extensive non-small cell carcinomas of the lung. Davis S; Rambotti P; Park YK Cancer Treat Rep; 1981; 65(11-12):955-8. PubMed ID: 7028257 [TBL] [Abstract][Full Text] [Related]
12. [A randomized comparison of radiotherapy with CAP and CVP in non-small cell lung cancer]. Yoneda S; Homma T; Yoshida S; Noguchi Y; Fukuda Y; Nakata M; Sakura M Gan To Kagaku Ryoho; 1986 Sep; 13(9):2870-1. PubMed ID: 3019254 [No Abstract] [Full Text] [Related]
13. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer. Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455 [TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy in advanced cancer of the lung]. Fleischer I; Wainstein R; Jovtis SL; Gibson AM; Barousse AP Medicina (B Aires); 1979; 39(4):472-6. PubMed ID: 545078 [No Abstract] [Full Text] [Related]
15. Combination chemotherapy followed by radiation therapy in patients with regional stage III unresectable non-small cell lung cancer. Fram R; Skarin A; Balikian J; Amato D; Leslie N; Malcolm A; Frei E Cancer Treat Rep; 1985 Jun; 69(6):587-90. PubMed ID: 2990710 [TBL] [Abstract][Full Text] [Related]
16. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer. Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980 [TBL] [Abstract][Full Text] [Related]
17. [VP-16, vincristine, adriamycin and cyclophosphamide (EVAC) in patients with small-cell lung cancer]. Abad-Esteve A; Rosell R; Moreno I; Fernández-Marcial C; Roselló M; Ribas Mundó M Med Clin (Barc); 1988 Apr; 90(14):569-72. PubMed ID: 2840536 [No Abstract] [Full Text] [Related]
18. Phase II studies of polychemotherapy regimens in small cell lung cancer. Eagan RT; Carr DT; Lee RE; Frytak S; Rubin J; Coles DT Cancer Treat Rep; 1977; 61(1):93-5. PubMed ID: 861966 [No Abstract] [Full Text] [Related]
19. Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung. Edmonson JH; Lagakos SW; Selawry OS; Perlia CP; Bennett JM; Muggia FM; Wampler G; Brodovsky HS; Horton J; Colsky J; Mansour EG; Creech R; Stolbach L; Greenspan EM; Levitt M; Israel L; Ezdinli EZ; Carbone PP Cancer Treat Rep; 1976 Jul; 60(7):925-32. PubMed ID: 1009523 [TBL] [Abstract][Full Text] [Related]
20. Combination chemoimmunotherapy for extensive non-oat cell lung cancer. Issell BF; Valdivieso M; Hersh EM; Richman S; Gutterman JU; Bodey GP Cancer Treat Rep; 1978 Jul; 62(7):1059-63. PubMed ID: 356968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]